San Francisco, California
London, United Kingdom
It is our pleasure to invite you to attend our annual scientific conference in conjunction with the American Academy of Dermatology annual meeting in the Columbine Room of the Sheraton Denver Downtown Hotel, Saturday, March 22, 2014, 5:30-7:30 pm. Our previous meetings have been tremendous successes (please find our meeting summary at: http://www.nanomedjournal.org/content/nanodermatologysociety)! Seating is limited, so please reserve your place.
For this coming year we have lined up an outstanding faculty of international nanotechnology experts from industry, academia, and government to speak on clinically important topics and on new and emerging technologies including: nanodrug delivery for cutaneous disease, nanosensors for diagnosis, and sunscreens. The current agenda includes:
Dr. Daniel Heller
Carbon Nanotubes as Biosensors
Dr. Heller trained with Dr. Robert Langer at MIT and has worked extensively with carbon nanotubes. He has developed assays using nanotubes for real-time detection of troponin release in the setting of acute cardiac disease. Two major promising applications of nanotechnology in biomedicine are the control over molecular binding sites and the detection of binding phenomena, which could lead to better therapies and earlier detection. Recent advances in the ability to control matter at the nanoscale have enabled unprecedented capabilities using semiconductor and polymeric materials. Bringing together expertise in nanoscience, chemistry, and biology, Dr. Heller's laboratory is developing these two classes of materials both alone and in combination to control molecular recognition. This work has a wide range of potential therapeutic and diagnostic applications.
Dr. Sarah Ibrahim
Challenges and Opportunities in Drug Delivery
Dr. Ibrahim is a pharmacologist with expertise in nanoformulation. She has years of academic and industry experience. She has been responsible for breakthroughs in transdermal, ocular and ungula drug delivery, iontophoresis, liposomes and nanoemulsions and has done this on a small scale in the laboratory and expanded this through industry experience in product/process development, formulation development, scale-up/technology transfer and process validation. She will be discussing the challenges and opportunities of nanoformulation for dermatology.
Dr. Mike Wilkerson
Photoactivation of Nanomaterials
Dr. Wilkerson is professor of dermatology at the University of Texas Medical Branch in Galveston. Dr. Wilkerson has an interest in the skin penetration and reactivity of nanoparticles. He will be discussing his latest findings on the reactivity of photoactivated of Rose Bengal.
Dr. Ross Kedl
Immune System Manipulation With Nanotechnology
Dr. Kedl studied T cell and dendritic cell interaction in the laboratory of Drs. Philippa Marrack and John Kappler, has extensive immunology experience in academia and industry. He has been awarded numerous patents for the augmentation of innate immunity through Toll-like receptors and is developing nanoadjuvants for vaccines that have the potential for commercial use. He will discuss his research and bench-to-bedside applications of his work.
When & Where
Our Executive Board
The Nanodermatology Society (NDS) was established in 2010 to promote a greater understanding of the scientific and medical aspects of nanotechnology in skin health and disease.
The Society is composed of physicians, dermatologists, physicists, chemists, policy makers, regulators, nanotechnology scientists, and students involved in nanotechnology specifically related to dermatology from teaching, to education, to scientific research.
For more information, please go to our web site www.nanodermsociety.org